CAAS Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

CAAS Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,000	Closed	-$514K	–	991
2022 Q4	$514K	Buy	+14,000	New	+$553K	0.03%	417
2021 Q3	–	Sell	-177,322	Closed	-$15.9M	–	1177
2021 Q2	$15.9M	Sell	177,322 -171,779	-49%	-$14.5M	0.27%	88
2021 Q1	$26.5M	Buy	349,101 +25,776	+8%	+$1.94M	0.29%	68
2020 Q4	$22M	Sell	323,325 -303,333	-48%	-$18.9M	0.21%	102
2020 Q3	$33.3M	Buy	+626,658	New	+$37.3M	0.78%	30

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

CAAS Capital Management's SYNH Position: Q1 2023 in Review

CAAS Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 14,000 shares — an estimated $514K sold.

CAAS Capital Management first reported a position in SYNH in Q3 2020 and held it in 5 quarters. The position peaked at $33.3M in Q3 2020. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

CAAS Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
CAAS Capital Management sold 14,000 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $514K.
CAAS Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2020 and held it in 5 quarters.
CAAS Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $33.3M in Q3 2020.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on CAAS Capital Management's 13F filing for Q1 2023, filed 15 May 2023.